ACTG (AIDS Clinical Trials Group) 384

July 17, 2017 | Autor: Robert Shafer | Categoria: Clinical Trial, Adolescent, HIV, Italy, Humans, United States, Female, Factorial Design, Male, Randomised Controlled Trial, Aged, Middle Aged, Adult, Protease Inhibitors, Controlled Clinical Trial, Reverse Transcriptase, United States, Female, Factorial Design, Male, Randomised Controlled Trial, Aged, Middle Aged, Adult, Protease Inhibitors, Controlled Clinical Trial, Reverse Transcriptase

Share Embed

Denunciar este link

Descrição do Produto

ACTG (AIDS Clinical Trials Group) 384 is designed to evaluate different strategies for antiretroviral treatment in HIV-1-infected individuals with no previous exposure to antiretroviral treatment. The study is a randomized, partially double-blinded, controlled trial with 980 subjects at 81 centers in the United States and Italy. The study has a factorial design that addresses the following scientific questions: (1) Does

Lihat lebih banyak...

ACTG (AIDS Clinical Trials Group) 384

Descrição do Produto

Comentários